Challenges for the evaluation of digital health solutions—A call for innovative evidence generation approaches
Abstract The field of digital health, and its meaning, has evolved rapidly over the last 20 years. For this article we followed the most recent definition provided by FDA in 2020. Emerging solutions offers tremendous potential to positively transform the healthcare sector. Despite the growing number...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-08-01
|
Series: | npj Digital Medicine |
Online Access: | https://doi.org/10.1038/s41746-020-00314-2 |
id |
doaj-5ade732f60c3479bb3b6e10171305a64 |
---|---|
record_format |
Article |
spelling |
doaj-5ade732f60c3479bb3b6e10171305a642021-08-29T11:10:14ZengNature Publishing Groupnpj Digital Medicine2398-63522020-08-013111410.1038/s41746-020-00314-2Challenges for the evaluation of digital health solutions—A call for innovative evidence generation approachesChaohui Guo0Hutan Ashrafian1Saira Ghafur2Gianluca Fontana3Clarissa Gardner4Matthew Prime5Roche DiagnosticsImperial College LondonImperial College LondonImperial College LondonImperial College LondonRoche DiagnosticsAbstract The field of digital health, and its meaning, has evolved rapidly over the last 20 years. For this article we followed the most recent definition provided by FDA in 2020. Emerging solutions offers tremendous potential to positively transform the healthcare sector. Despite the growing number of applications, however, the evolution of methodologies to perform timely, cost-effective and robust evaluations have not kept pace. It remains an industry-wide challenge to provide credible evidence, therefore, hindering wider adoption. Conventional methodologies, such as clinical trials, have seldom been applied and more pragmatic approaches are needed. In response, several academic centers such as researchers from the Institute of Global Health Innovation at Imperial College London have initiated a digital health clinical simulation test bed to explore new approaches for evidence gathering relevant to solution type and maturity. The aim of this article is to: (1) Review current research approaches and discuss their limitations; (2) Discuss challenges faced by different stakeholders in undertaking evaluations; and (3) Call for new approaches to facilitate the safe and responsible growth of the digital health sector.https://doi.org/10.1038/s41746-020-00314-2 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Chaohui Guo Hutan Ashrafian Saira Ghafur Gianluca Fontana Clarissa Gardner Matthew Prime |
spellingShingle |
Chaohui Guo Hutan Ashrafian Saira Ghafur Gianluca Fontana Clarissa Gardner Matthew Prime Challenges for the evaluation of digital health solutions—A call for innovative evidence generation approaches npj Digital Medicine |
author_facet |
Chaohui Guo Hutan Ashrafian Saira Ghafur Gianluca Fontana Clarissa Gardner Matthew Prime |
author_sort |
Chaohui Guo |
title |
Challenges for the evaluation of digital health solutions—A call for innovative evidence generation approaches |
title_short |
Challenges for the evaluation of digital health solutions—A call for innovative evidence generation approaches |
title_full |
Challenges for the evaluation of digital health solutions—A call for innovative evidence generation approaches |
title_fullStr |
Challenges for the evaluation of digital health solutions—A call for innovative evidence generation approaches |
title_full_unstemmed |
Challenges for the evaluation of digital health solutions—A call for innovative evidence generation approaches |
title_sort |
challenges for the evaluation of digital health solutions—a call for innovative evidence generation approaches |
publisher |
Nature Publishing Group |
series |
npj Digital Medicine |
issn |
2398-6352 |
publishDate |
2020-08-01 |
description |
Abstract The field of digital health, and its meaning, has evolved rapidly over the last 20 years. For this article we followed the most recent definition provided by FDA in 2020. Emerging solutions offers tremendous potential to positively transform the healthcare sector. Despite the growing number of applications, however, the evolution of methodologies to perform timely, cost-effective and robust evaluations have not kept pace. It remains an industry-wide challenge to provide credible evidence, therefore, hindering wider adoption. Conventional methodologies, such as clinical trials, have seldom been applied and more pragmatic approaches are needed. In response, several academic centers such as researchers from the Institute of Global Health Innovation at Imperial College London have initiated a digital health clinical simulation test bed to explore new approaches for evidence gathering relevant to solution type and maturity. The aim of this article is to: (1) Review current research approaches and discuss their limitations; (2) Discuss challenges faced by different stakeholders in undertaking evaluations; and (3) Call for new approaches to facilitate the safe and responsible growth of the digital health sector. |
url |
https://doi.org/10.1038/s41746-020-00314-2 |
work_keys_str_mv |
AT chaohuiguo challengesfortheevaluationofdigitalhealthsolutionsacallforinnovativeevidencegenerationapproaches AT hutanashrafian challengesfortheevaluationofdigitalhealthsolutionsacallforinnovativeevidencegenerationapproaches AT sairaghafur challengesfortheevaluationofdigitalhealthsolutionsacallforinnovativeevidencegenerationapproaches AT gianlucafontana challengesfortheevaluationofdigitalhealthsolutionsacallforinnovativeevidencegenerationapproaches AT clarissagardner challengesfortheevaluationofdigitalhealthsolutionsacallforinnovativeevidencegenerationapproaches AT matthewprime challengesfortheevaluationofdigitalhealthsolutionsacallforinnovativeevidencegenerationapproaches |
_version_ |
1721187037809213440 |